Expression of long non-coding RNA in patients with non-IgA mesangial proliferative glomerulonephritis

Objective To study differential expression profile of mRNA and long non-coding RNA(IncRNA) through microarray analysis between non-IgA mesangial proliferative glomerulonephritis(MsPGN) patients and the controls,and then explore the potential role of IncRNA in the pathogenesis of non-IgA MsPGN.Method...

Full description

Bibliographic Details
Published in:	Linchuang shenzangbing zazhi
Main Authors:	CONG Shan, SUI Wei-guo, ZOU Gui-mian, XUE Wen, LI Huan, YAN Qiang, CHEN Jie-jing, LUO Ya-dan, CHEN Huai-zhou
Format:	Article
Language:	Chinese
Published:	Editorial Department of Journal of Clinical Nephrology 2015-01-01
Subjects:	Long non-coding RNA non-IgA mesangial proliferative glomerulonephritis Differential expression Microarray
Online Access:	http://www.lcszb.com/thesisDetails?columnId=57920990&Fpath=home&index=0

Similar Items

IgA nephropathy with monotypic IgA-κ deposits: a case report and literature review
by: Xiao-Ying Li, et al.
Published: (2025-10-01)

Case report: in focus IgA nephropathy as a gluten-related disorder
by: M. E. Mantsaeva, et al.
Published: (2021-07-01)

Effect of astragaloside on renal function and serum IL-1β and IL-17 in mice with mesangial proliferative glomerulonephritis
by: LIANG Wen-lin, LI Jun, JIN Guang-ming, YAN Jin-sheng, YAO Yuan
Published: (2020-12-01)

Tetrandrine inhibits the proliferation of mesangial cells induced by enzymatically deglycosylated human IgA1 via IgA receptor/MAPK/NF-κB signaling pathway
by: Wencheng Xu, et al.
Published: (2023-06-01)

Turner syndrome complicated with mesangial proliferative nephritis: one case report with a literature review
by: Min Lu, et al.
Published: (2024-01-01)

Clinical features and prognosis of patients with anti-GBM disease combined with mesangial IgA deposition
by: Wei Ning, et al.
Published: (2024-07-01)

Medium from mesangial cells incubated with aggregated IgA1 from IgA nephropathy patients reduces podocyte adhesion through activation of the renin angiotensin system
by: C Wang, et al.
Published: (2011-12-01)

Prognostic role of mesangial IgM deposition in IgA nephropathy: a long-term cohort study
by: Gabriel Stefan, et al.
Published: (2024-12-01)

IgA Enhances IGF-1 Mitogenic Activity Via Receptor Modulation in Glomerular Mesangial Cells: Implications for IgA-Induced Nephropathy
by: Amal Al-Eisa, et al.
Published: (2017-06-01)

Effect of Huaier On the Proliferation of Mesangial Cells in Anti-Thy-1 Nephritis
by: Jiuxu Bai, et al.
Published: (2017-08-01)

IgA1 dominant subclass of latent IgA mesangial deposition in donated kidney
by: Oka K, et al.
Published: (2016-11-01)

IgA Vasculitis and C3 Glomerulonephritis: One Patient... Various Autoimmune Diseases
by: Ana Margarida Pedro Antunes Ferreira Gaudêncio, et al.
Published: (2022-11-01)

IgA Vasculitis and C3 Glomerulonephritis: One Patient... Various Autoimmune Diseases
by: Ana Margarida Pedro Antunes Ferreira Gaudêncio, et al.
Published: (2022-11-01)

Proliferative glomerulonephritis with monoclonal IgG Lambda deposits caused by plasmablastic lymphoma: a case report
by: Ling-Yan Ren, et al.
Published: (2023-10-01)

Personal thoughts of IgA nephropathy and purpura nephritis in children
by: Zhang Hong-wen
Published: (2022-07-01)

A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report
by: Daisuke Ito, et al.
Published: (2022-12-01)

Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report
by: Tadasu Kojima, et al.
Published: (2019-01-01)

Immunoglobulin M nephropathy nephropathy in adults and adolescents in India: A single-center study of natural history
by: A M Singhai, et al.
Published: (2011-01-01)

Management of IgA Nephropathy in Pediatric Patients
by: Sophie Schroda, et al.
Published: (2022-05-01)

A case of crescentic glomerulonephritis with exacerbation of pre-existing IgA nephropathy after COVID-19
by: Esra Karabağ Yılmaz, et al.
Published: (2024-02-01)

Correlation between serum homocysteine level and clinicopathological factors of IgA nephropathy
by: Cai Xiao-fan, et al.
Published: (2025-01-01)

Promising response of proliferative glomerulonephritis with monoclonal IgG deposits to low-dose daratumumab: a case report
by: Hongyao Xu, et al.
Published: (2024-07-01)

Early clinical course of biopsy-proven IgA vasculitis nephritis
by: Sarina Butzer, et al.
Published: (2022-10-01)

HIV infection complicated with IgA nephropathy: one case report with a literature review
by: Liu Jing, et al.
Published: (2022-09-01)

IgM kappa proliferative glomerulonephritis with monoclonal immunoglobulin deposition complicated with nocardiosis dermatitis: a case report and review of literature
by: Kebao Chen, et al.
Published: (2024-04-01)

The Clinical Significance and Potential Role of Cathepsin S in IgA Nephropathy
by: Jingying Zhao, et al.
Published: (2021-04-01)

Recent advances on non-immunosuppressive treatment of IgA nephropathy
by: Ding Wan, et al.
Published: (2025-07-01)

Infection-related immunoglobulin A nephropathy or IgA-dominant postinfectious glomerulonephritis; what is in a name?
by: Ghazal Ghasempoor Dabaghi, et al.
Published: (2021-07-01)

Clinical analysis of 30 cases of patients with nutcracker syndrome complicated with IgA nephropathy
by: WANG Ming-jun, et al.
Published: (2019-01-01)

Gut microbial metabolite, sphingosine-1-phosphate (S1P), drives mesangial cell phenotypic transformation and accelerates progression of IgA nephropathy via CCL2-MET-FAK pathway
by: Yu-yan Tang, et al.
Published: (2025-01-01)

Comparison of real-world kidney outcomes with predicted outcomes at the time of diagnosis and post-biopsy in a cohort of children with IgA nephropathy
by: Mafalda Félix Cabral, et al.
Published: (2025-04-01)

Analysis of risk factors for the prognosis of proliferative IgA nephropathy and construction of a prediction model
by: Zhu Feng-bo, et al.
Published: (2025-07-01)

Profiling and initial validation of urinary microRNAs as biomarkers in IgA nephropathy
by: Nannan Wang, et al.
Published: (2015-06-01)

The Prevalence and Characteristics of IgA Antibodies to β2-Spectrin and CBX3 in Immunoglobulin A Nephropathy
by: Ayako Koizumi, et al.
Published: (2025-05-01)

Correlation analysis of clinical parameters and prognosis in different pathological grades of primary IgA nephropathy
by: Ren Hui-min, et al.
Published: (2021-01-01)

Contemporary review of IgA nephropathy
by: Edward J. Filippone, et al.
Published: (2024-08-01)

Hypocomplementemic Atypical IgA Vasculitis: A Case Report
by: Melvin Chan, et al.
Published: (2022-06-01)

One case report of proliferative glomerulonephritis with monoclonal immunoglobulin G3-kappa deposits with HCV hepatitis infection
by: Xu Chao, et al.
Published: (2021-01-01)

Pathological patterns of mesangioproliferative glomerulonephritis seen at a tertiary care center
by: Mokhtar Ghadeer A., et al.
Published: (2014-04-01)

Randomized Trial on the Effect of an Oral Spleen Tyrosine Kinase Inhibitor in the Treatment of IgA Nephropathy
by: Frederick W.K. Tam, et al.
Published: (2023-12-01)